ASMB

Assembly Biosciences, Inc. is a biopharmaceutical company focused on developing novel treatments for serious viral and liver diseases. Its clinical programs target herpesviruses, hepatitis delta virus (HDV), cholestatic liver diseases, and hepatitis B virus (HBV). The company leverages its expertise in virology and liver disease to advance therapeutic candidates aimed at improving patient outcomes in these areas. Assembly Biosciences operates primarily in the biopharmaceutical sector, conducting research and development to create impactful therapies for affected individuals.